SCCM Resource Library-Word on the Street: Updates in Toxicology

Video Transcription

Video Summary

In this video, Rachel Wein, an Emergency Medicine Clinical Pharmacist, discusses two exciting updates in pharmacology. The first update focuses on the use of rivastigmine as an alternative to phizostigmine in anticholinergic overdose. Rivastigmine, commonly used to treat dementia, has shown promising results in treating anticholinergic toxicity. The second update discusses the use of femepizole as an adjunct therapy for massive acetaminophen toxicity. Femepizole, known for its inhibition of alcohol dehydrogenase, has demonstrated positive outcomes in reducing hepatocellular injury in acetaminophen overdose cases. Both rivastigmine and femepizole offer potential benefits in toxicological emergencies and should be considered as treatment options.

Asset Subtitle

Pharmacology, 2023

Asset Caption

Type: year in review | Year in Review: Clinical Pharmacy and Pharmacology (SessionID 2000002)

Meta Tag

Content Type Presentation

Knowledge Area Pharmacology

Membership Level Professional

Membership Level Select

Tag Toxicology

Year 2023

Keywords

rivastigmine

anticholinergic overdose

femepizole

acetaminophen toxicity

toxicological emergencies

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.